QJI

Interoperable Automated Glycemic Controller

Product code
QJI
Device name
Interoperable Automated Glycemic Controller
Device class
Class 2
21 CFR
21 CFR 862.1356
Medical specialty
Clinical Chemistry
Marketing pathway
510(K)
510(k) clearances (last 3 years)
16
Summaries archived here
14 (direct download)
510(k) clearances (all years, FDA)
22 (all years; only the last 3 years are listed here)

FDA classification definition

An interoperable automated glycemic controller is a device intended to automatically calculate drug doses based on inputs such as glucose and other relevant physiological parameters, and to command the delivery of such drug doses from a connected infusion pump. Interoperable automated glycemic controllers are designed to reliably and securely communicate with digitally connected devices to allow drug delivery commands to be sent, received, executed, and confirmed. Interoperable automated glycemic controllers are intended to be used in conjunction with digitally connected devices for the purpose of maintaining glycemic control.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (16)

Last three years. Most recent: 2026-07-09.

NumberDecision dateApplicantDevice nameSummary
K2619622026-07-09Medtronic MiniMedSmartGuard Technology; Predictive Low Glucose Techno…FDA
K2614612026-06-29Insulet CorporationOmnipod 6 algorithmPDF
K2604292026-04-24Tandem Diabetes Care, Inc.Control-IQ+ technologyPDF
K2537012026-02-03Medtronic MinimedSmartGuard Technology; Predictive Low Glucose Techno…PDF
K2535852026-01-14Medtronic Minimed, Inc.SmartGuard technology; Predictive Low Glucose techno…PDF
K2511522025-12-19DiabeloopDBLG2PDF
K2517792025-12-03Insulet CorporationOmnipod 5 algorithmPDF
K2512172025-08-29Medtronic Minimed, Inc.SmartGuard technology; Predictive Low Glucose techno…PDF
K2507982025-05-21Tandem Diabetes Care, Inc.Control-IQ+ technologyPDF
K2438232025-02-24Tandem Diabetes Care, Inc.Control-IQ+ technologyPDF
K2417772024-08-26Insulet CorporationSmartAdjust™ TechnologyPDF
K2327412024-05-29Insulet CorporationSmartAdjust(TM) technologyPDF
K2326032024-05-23Camdiab , Ltd.CamAPS FX
K2340552024-03-13Deka Research and DevelopmentDEKA LoopPDF
K2323822023-11-03Tandem Diabetes Care, Inc.Control-IQ TechnologyPDF
K2322242023-09-22Beta Bionics, Inc.iLet® Dosing Decision SoftwarePDF

14 summaries are archived here for direct download.

Official FDA classification page: QJI
Classification and pathway per current FDA publications. Data from openFDA (CC0).